CapEx at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's capex?
- Ionis Pharmaceuticals (IONS) reported capex of $21.76M in Q1 2026.
- How has Ionis Pharmaceuticals's capex changed year-over-year?
- Ionis Pharmaceuticals's capex increased by 73.0% year-over-year, from $12.58M to $21.76M.
- What is the long-term trend for Ionis Pharmaceuticals's capex?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's capex has grown at a 44.0% compound annual growth rate (CAGR), from $11.96M to $51.44M.
- What does capex mean?
- Cash spent on physical assets like buildings, machinery, or equipment.
- How do you interpret capex?
- High spending indicates investment in future growth or infrastructure, while low spending may indicate a focus on asset-light operations or capital efficiency.
- How does capex compare across companies?
- Standard measure of capital intensity across all industries.